ClinVar Genomic variation as it relates to human health
NM_000243.3(MEFV):c.1016C>T (p.Ser339Phe)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_000243.3(MEFV):c.1016C>T (p.Ser339Phe)
Variation ID: 36497 Accession: VCV000036497.34
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 16p13.3 16: 3249675 (GRCh38) [ NCBI UCSC ] 16: 3299675 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Mar 6, 2014 Oct 8, 2024 Mar 27, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_000243.3:c.1016C>T MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_000234.1:p.Ser339Phe missense NM_001198536.2:c.383C>T NP_001185465.2:p.Ser128Phe missense NC_000016.10:g.3249675G>A NC_000016.9:g.3299675G>A NG_007871.1:g.11953C>T LRG_190:g.11953C>T LRG_190t1:c.1016C>T LRG_190p1:p.Ser339Phe - Protein change
- S339F, S128F
- Other names
- -
- Canonical SPDI
- NC_000016.10:3249674:G:A
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
-
0.00020 (A)
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
The Genome Aggregation Database (gnomAD), exomes 0.00019
1000 Genomes Project 0.00020
NHLBI Exome Sequencing Project (ESP) Exome Variant Server 0.00023
Trans-Omics for Precision Medicine (TOPMed) 0.00014
1000 Genomes Project 30x 0.00016
The Genome Aggregation Database (gnomAD) 0.00016
Exome Aggregation Consortium (ExAC) 0.00019
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
MEFV | No evidence available | No evidence available |
GRCh38 GRCh37 |
957 | 1258 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Uncertain significance (6) |
criteria provided, multiple submitters, no conflicts
|
Oct 25, 2022 | RCV000030169.15 | |
Uncertain significance (4) |
criteria provided, multiple submitters, no conflicts
|
Jan 26, 2024 | RCV000366739.10 | |
Uncertain significance (1) |
criteria provided, single submitter
|
Feb 15, 2019 | RCV001001441.8 | |
Uncertain significance (1) |
criteria provided, single submitter
|
Jul 1, 2018 | RCV002262577.3 | |
Uncertain significance (1) |
criteria provided, single submitter
|
Mar 27, 2024 | RCV003466877.3 | |
MEFV-related disorder
|
Uncertain significance (1) |
no assertion criteria provided
|
Jul 18, 2024 | RCV004739311.1 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Uncertain significance
(Mar 27, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Familial Mediterranean fever, autosomal dominant
Affected status: unknown
Allele origin:
unknown
|
Baylor Genetics
Accession: SCV004194409.3
First in ClinVar: Dec 30, 2023 Last updated: Jun 17, 2024 |
|
|
Uncertain significance
(Feb 15, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
not specified
Affected status: unknown
Allele origin:
germline
|
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Accession: SCV001158679.1
First in ClinVar: Feb 10, 2020 Last updated: Feb 10, 2020 |
Comment:
The MEFV c.1016C>T; p.Ser339Phe (rs104895157) is reported in the Infevers database in an individual without a described phenotype (see link below). The variant is reported … (more)
The MEFV c.1016C>T; p.Ser339Phe (rs104895157) is reported in the Infevers database in an individual without a described phenotype (see link below). The variant is reported in the ClinVar database (Variation ID: 36497) and in the general population with an overall allele frequency of 0.02% (50/279412 alleles) in the Genome Aggregation Database. The serine at this position is moderately conserved and computational analyses (SIFT: tolerated, PolyPhen-2: possibly damaging) predict conflicting effects of this variant on protein structure/function. Due to limited information, the clinical significance of the variant is uncertain at this time. References: Link to Infevers database: https://infevers.umai-montpellier.fr/web/search.php?n=1 (less)
|
|
Uncertain significance
(Jun 14, 2017)
|
criteria provided, single submitter
Method: clinical testing
|
Familial Mediterranean fever
Affected status: unknown
Allele origin:
germline
|
Illumina Laboratory Services, Illumina
Accession: SCV001279958.1
First in ClinVar: May 31, 2020 Last updated: May 31, 2020 |
Comment:
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, … (more)
This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. (less)
|
|
Uncertain significance
(Jul 14, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
Familial Mediterranean fever
Affected status: no
Allele origin:
germline
|
Genome-Nilou Lab
Accession: SCV001805999.1
First in ClinVar: Aug 25, 2021 Last updated: Aug 25, 2021 |
Sex: mixed
|
|
Uncertain significance
(Jul 01, 2018)
|
criteria provided, single submitter
Method: clinical testing
|
Autoinflammatory syndrome
Affected status: yes
Allele origin:
germline
|
Genome Diagnostics Laboratory, The Hospital for Sick Children
Accession: SCV002543684.1
First in ClinVar: Jul 09, 2022 Last updated: Jul 09, 2022 |
|
|
Uncertain significance
(Feb 09, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV000329420.7
First in ClinVar: Dec 06, 2016 Last updated: Jul 24, 2021 |
Comment:
Reported in a patient with periodic fever in published literature (Federici et al., 2012); In silico analysis supports that this missense variant has a deleterious … (more)
Reported in a patient with periodic fever in published literature (Federici et al., 2012); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 22580583, 28421071, 30476289, 26247045) (less)
|
|
Uncertain significance
(Oct 25, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Familial Mediterranean fever
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV000940571.4
First in ClinVar: Aug 14, 2019 Last updated: Feb 07, 2023 |
Comment:
This sequence change replaces serine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 339 of the MEFV protein (p.Ser339Phe). … (more)
This sequence change replaces serine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 339 of the MEFV protein (p.Ser339Phe). This variant is present in population databases (rs104895157, gnomAD 0.06%). This missense change has been observed in individual(s) with familial Mediterranean fever (PMID: 21413889, 22580583, 22903357, 31989427). ClinVar contains an entry for this variant (Variation ID: 36497). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. (less)
|
|
Uncertain significance
(Jan 26, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
Clinical Genetics and Genomics, Karolinska University Hospital
Accession: SCV001449584.2
First in ClinVar: Dec 11, 2020 Last updated: Feb 04, 2024 |
Number of individuals with the variant: 1
|
|
Uncertain significance
(Oct 02, 2015)
|
no assertion criteria provided
Method: clinical testing
|
Familial Mediterranean Fever
Affected status: unknown
Allele origin:
germline
|
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Accession: SCV000052827.2
First in ClinVar: Apr 04, 2013 Last updated: Mar 06, 2014 |
|
|
Uncertain significance
(Sep 16, 2020)
|
no assertion criteria provided
Method: clinical testing
|
Familial Mediterranean fever
Affected status: unknown
Allele origin:
germline
|
Natera, Inc.
Accession: SCV001452082.1
First in ClinVar: Jan 02, 2021 Last updated: Jan 02, 2021 |
|
|
Uncertain significance
(-)
|
no assertion criteria provided
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
Genome Diagnostics Laboratory, University Medical Center Utrecht
Additional submitter:
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Study: VKGL Data-share Consensus
Accession: SCV001927517.1 First in ClinVar: Sep 24, 2021 Last updated: Sep 24, 2021 |
|
|
Uncertain significance
(-)
|
no assertion criteria provided
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Additional submitter:
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Study: VKGL Data-share Consensus
Accession: SCV001953208.1 First in ClinVar: Oct 02, 2021 Last updated: Oct 02, 2021 |
|
|
Uncertain significance
(Jul 18, 2024)
|
no assertion criteria provided
Method: clinical testing
|
MEFV-related condition
Affected status: unknown
Allele origin:
germline
|
PreventionGenetics, part of Exact Sciences
Accession: SCV005344956.1
First in ClinVar: Oct 08, 2024 Last updated: Oct 08, 2024 |
Comment:
The MEFV c.1016C>T variant is predicted to result in the amino acid substitution p.Ser339Phe. This variant has been reported the heterozygous and compound heterozygous states … (more)
The MEFV c.1016C>T variant is predicted to result in the amino acid substitution p.Ser339Phe. This variant has been reported the heterozygous and compound heterozygous states in multiple individuals with familial Mediterranean fever (Berdeli et al. 2011. PubMed ID: 21413889; Balta et al. 2020. PubMed ID: 31989427; Lainka et al. 2012. PubMed ID: 22903357; Federici et al. 2012. PubMed ID: 22580583). This variant is reported in 0.049% of alleles in individuals of Ashkenazi Jewish descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. (less)
|
|
not provided
(-)
|
no classification provided
Method: not provided
|
Familial Mediterranean fever
Affected status: not provided
Allele origin:
unknown
|
Unité médicale des maladies autoinflammatoires, CHRU Montpellier
Accession: SCV000115765.1
First in ClinVar: Mar 06, 2014 Last updated: Mar 06, 2014 |
|
|
click to load more click to collapse |
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
A comprehensive molecular analysis and genotype-phenotype correlation in patients with familial mediterranean fever. | Balta B | Molecular biology reports | 2020 | PMID: 31989427 |
Monogenic Autoinflammatory Diseases with Mendelian Inheritance: Genes, Mutations, and Genotype/Phenotype Correlations. | Martorana D | Frontiers in immunology | 2017 | PMID: 28421071 |
Global epidemiology of Familial Mediterranean fever mutations using population exome sequences. | Fujikura K | Molecular genetics & genomic medicine | 2015 | PMID: 26247045 |
Familial Mediterranean fever in Germany: epidemiological, clinical, and genetic characteristics of a pediatric population. | Lainka E | European journal of pediatrics | 2012 | PMID: 22903357 |
Clinical impact of MEFV mutations in children with periodic fever in a prevalent western European Caucasian population. | Federici S | Annals of the rheumatic diseases | 2012 | PMID: 22580583 |
Comprehensive analysis of a large-scale screen for MEFV gene mutations: do they truly provide a "heterozygote advantage" in Turkey? | Berdeli A | Genetic testing and molecular biomarkers | 2011 | PMID: 21413889 |
Text-mined citations for rs104895157 ...
HelpRecord last updated Oct 13, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.